Ranis Tablet (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.
MFDS item code 199202243 · Notified 1992.01.22
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (e.g., ulcers); improvement of gastric mucosal lesions; relief of hyperacidity, etc. (liquid formulation)
This medication is used to treat ulcers formed in the stomach and duodenum, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent Mendelson's syndrome during preoperative anesthesia and can prevent ulcers post-surgery. It is effective for treating gastric ulcers caused by the use of non-steroidal anti-inflammatory drugs (NSAIDs). It improves lesions such as erosion, bleeding, redness, and edema of the gastric mucosa in cases of acute exacerbation of acute and chronic gastritis. Additionally, it is used to relieve upper gastrointestinal bleeding due to peptic ulcers and acute stress ulcers, and to reduce symptoms of heartburn and regurgitation caused by excessive gastric acid. Overall, it provides good effects for treating gastrointestinal diseases and protecting the gastric mucosa.
Administer 150 mg of ranitidine per dose twice daily, in the morning and at bedtime, by mouth. Gastric and duodenal ulcers: Administer this medicine at 150 mg per dose twice daily by mouth, or 300 mg once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 300 mg per dose twice daily, in the morning and at bedtime. The dosage and administration are the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although the healing period may occasionally be prolonged in some patients. Maintenance therapy for recurrent ulcers: Administer 150 mg once daily at bedtime. Reflux esophagitis: Administer this medicine at 150 mg per dose twice daily for 8 weeks, or 300 mg once daily at bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg per dose 4 times daily. Zollinger-Ellison syndrome: Start treatment with an initial dose of 150 mg per dose 3 times daily, and increase the dose as needed. In severe cases, up to 6 g per day may be administered as directed by a physician. Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions: Administer this medicine at 150 mg per dose twice daily. Pre-anesthetic medication (prevention of Mendelson's syndrome): Administer 150 mg of this medicine 2 hours before induction of anesthesia. In this case, it is preferable to also administer 150 mg on the night before surgery. Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) associated with acute gastritis or acute exacerbations of chronic gastritis: Administer this medicine at 150 mg per dose once daily at bedtime. Patients with severe renal impairment and creatinine clearance of 50 mL/min or less: Administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Patients aged 12 years and older: Administer this medicine at 75 mg per dose twice daily by mouth (oral solution only). Ages 8 〜 18: Up to 150 mg per dose (2 mg per kg of body weight) may be administered twice daily.
This drug should not be used in patients with hypersensitivity to any of its components. It should not be administered to patients with a history of acute porphyria as it may trigger an acute attack. As it contains lactose, it should not be used in patients with lactose intolerance or specific genetic metabolic disorders. In patients with impaired renal function, this medication can stay in the body longer, so the dose should be reduced or the dosing interval should be extended. It should also be used cautiously in patients with impaired liver function. Past drug allergy sufferers should use this medication carefully. Elderly patients are at higher risk of side effects, so caution is required. Patients taking NSAIDs need regular health checks, especially. Gastric cancer symptoms can be masked, so patients over middle age with gastric ulcers or newly developed or changed dyspeptic symptoms should be screened for malignancy before treatment. Patients with Helicobacter pylori infection and gastric or duodenal ulcers should undergo eradication therapy simultaneously. Rarely, this medication can cause serious allergic reactions, blood abnormalities, liver dysfunction, cardiac rhythm disturbances, gastrointestinal issues, neurological problems, and skin rashes. If any unusual symptoms occur, stop using it immediately and consult a doctor. During treatment, closely observe the disease course, and if ineffective, switch to other treatment methods. There may be an increased risk of pneumonia in the elderly or patients with chronic diseases, so caution is warranted. If dizziness or drowsiness develops after taking this medication, avoid driving or operating hazardous machinery. There may be interactions with other drugs, so you must inform your healthcare provider about any concurrent medications. Especially with anticoagulants or certain heart medications, blood coagulation status should be closely monitored. Women who are pregnant or may become pregnant or are breastfeeding should only use this drug cautiously when necessary. Safety in children has not been adequately established, so caution is needed when using. Elderly patients may experience increased drug concentration due to decreased kidney function, requiring dosage adjustments. No specific severe problems have been reported with overdose, but appropriate treatment such as vomiting or gastric lavage may be required. Keep this medication out of reach of children and avoid transferring it to other containers.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a container protected from light and air, preferably at a temperature between 1 and 30 degrees Celsius. This way, the effectiveness of the drug is well preserved and its degradation can be prevented.
Off-white to yellowish round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.